Acute Kidney Injury (AKI) Phase II

Initiated at Mayo Clinic, this human clinical trial is evaluating the efficacy of Basis for the prevention of AKI in surgical cardiac patients. This study is estimated to complete in December 2023. ClinicalTrials.gov Identifier: NCT04342975

Related Articles: